Clinical trial
Palliative Care Study in Patients With Advanced Cancer
NCT00127517 · Advanced Viral Research Corp, Industry · Terminated
Key facts
| NCT number | NCT00127517 |
|---|---|
| Title | Palliative Care Study in Patients With Advanced Cancer |
| Official title | A Phase II Double Blind, Placebo Controlled, Randomized, > Multicenter Study With AVR118 Solution in Patients With Advanced > Malignancies Who Are Not Candidates for Curative Chemotherapy. |
| Lead sponsor | Advanced Viral Research Corp, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | peptide-nucleic acid solution AVR118 |
| Start date | Mar 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Aug 8, 2005 |
| Last update posted | Jun 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: